Cdc14 Phosphatase Antibodies

Santa Cruz Biotechnology features a diverse variety of Cdc14 Phosphatase monoclonal antibodies for research in cell cycle regulation and mitotic processes. Cdc14 Phosphatase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc14 phosphatase plays a critical role in the regulation of mitosis and the exit from mitosis, ensuring proper cell division and genomic stability. By dephosphorylating key substrates, Cdc14 phosphatase helps to coordinate the timing of cell cycle events, making it essential for maintaining cellular homeostasis. Dysregulation of Cdc14 activity has been implicated in various diseases, including cancer, highlighting its importance as a target for therapeutic intervention. Researchers can utilize Cdc14 phosphatase monoclonal antibodies to explore cellular mechanisms and pathways involved in cell cycle progression. Understanding Cdc14 phosphatase function through detailed molecular studies can reveal new insights into disease development and potential treatments. Santa Cruz Biotechnology monoclonal antibodies for Cdc14 phosphatase enable researchers worldwide to advance scientific knowledge in cell cycle regulation and disease mechanisms.